{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/19/3347529/0/en/tearcare-becomes-the-first-and-only-mgd-treatment-indicated-to-improve-meibomian-gland-function-in-patients-with-evaporative-dry-eye-disease.html", "message": "News view counter 891784 successfully enlarged"}